Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury

Biological/cell based
General health
Online since 16 April 2024, updated 51 days ago

About this trial

This is a phase I/IIa, randomized, double-blind, two-arms, two-dose administration, placebo controlled, two-way crossover clinical trial in which 10 patients from 18 to 65 years of age affected with c...

Included participants

Gender
All
Age
18 - 65 years
Injury level
T2 - T11
  • Severity (AIS)?
  • AIS-A
    Time since injury
    12 months - 5 years
  • Injury type
  • Traumatic

    Healthy volunteers
    No
    T2-T11

    What’s involved

    Type

    Biological/cell based

    Details

    There are no details yet

    Potential benefits

    Main benefits

    General health

    Additional benefits

    Bladder health/function

    Mental health and psychosocial factors

    Pain

    Sensory function

    Spasticity

    Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more

    • Trial recruitment status
    • Ended
    • Trial start date
    • 27 Dec 2016
    • Organisation
    • Banc de Sang i Teixits
    • Trial recruitment status
    • Ended
    • Trial start date
    • 27 Dec 2016
    • Organisation
    • Banc de Sang i Teixits

    Wings for Life supports SCITrialsFinder

    Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.

    Learn more